These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3885030)

  • 21. A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance.
    Wang P; Sims PF; Hyde JE
    Parasitology; 1997 Sep; 115 ( Pt 3)():223-30. PubMed ID: 9300459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya.
    Spencer HC; Watkins WM; Sixsmith DG; Koech DK; Chulay JD
    Bull World Health Organ; 1984; 62(4):615-21. PubMed ID: 6386209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mefloquine sulfadoxine pyrimethamine (MSP) combination delays in vitro emergence of mefloquine resistance in multiple drug resistant Plasmodium falciparum.
    Brockelman CR; Thanomsub B; Bhisutthibhand J
    Southeast Asian J Trop Med Public Health; 1989 Sep; 20(3):371-8. PubMed ID: 2699083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative reversal by vitamins (rho-aminobenzoic, folic, and folinic acids) of the effects of sulfadiazine and pyrimethamine on Toxoplasma, mouse and man.
    FRENKEL JK; HITCHINGS GH
    Antibiot Chemother (Northfield); 1957 Dec; 7(12):630-8. PubMed ID: 24544594
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasmodium falciparum in Haiti: susceptibility to pyrimethamine and sulfadoxine-pyrimethamine.
    Nguyen-Dinh P; Zevallos-Ipenza A; Magloire R
    Bull World Health Organ; 1984; 62(4):623-6. PubMed ID: 6386210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutritional requirements of Plasmodium falciparum in culture. III. Further observations on essential nutrients and antimetabolites.
    Geary TG; Divo AA; Bonanni LC; Jensen JB
    J Protozool; 1985 Nov; 32(4):608-13. PubMed ID: 2866244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viability of Plasmodium falciparum ex vivo: comparison of the effects of artemether and sulfadoxine-pyrimethamine.
    Sowunmi A; Oduola AM
    Eur J Clin Pharmacol; 1998 May; 54(3):221-6. PubMed ID: 9681663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization.
    Wang P; Read M; Sims PF; Hyde JE
    Mol Microbiol; 1997 Mar; 23(5):979-86. PubMed ID: 9076734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren.
    Landgraf B; Kollaritsch H; Wiedermann G; Wernsdorfer WH
    Trans R Soc Trop Med Hyg; 1994; 88(4):440-2. PubMed ID: 7570837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.
    Kinyanjui SM; Mberu EK; Winstanley PA; Jacobus DP; Watkins WM
    Am J Trop Med Hyg; 1999 Jun; 60(6):943-7. PubMed ID: 10403325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Fansidar against Plasmodium falciparum in continuous culture.
    Brockelman CR; Tan-Ariya P
    Am J Trop Med Hyg; 1982 Sep; 31(5):913-8. PubMed ID: 6751112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standard and reduced doses of sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum in Tanzania, with determination of drug concentrations and susceptibility in vitro.
    Hellgren U; Kihamia CM; Bergqvist Y; Lebbad M; Premji Z; Rombo L
    Trans R Soc Trop Med Hyg; 1990; 84(4):469-72. PubMed ID: 2091329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimalarial and toxic effect of triple combination of pyronaridine, sulfadoxine and pyrimethamine.
    Shao BR; Huang ZS; Shi XH; Zhan CQ; Meng F; Ye XY; Huang J; Ha SH
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):257-63. PubMed ID: 2692191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amodiaquine and sulfadoxine-pyrimethamine as treatment for chloroquine-resistant Plasmodium falciparum in Rwanda.
    Deloron P; Sexton JD; Bugilimfura L; Sezibera C
    Am J Trop Med Hyg; 1988 Mar; 38(2):244-8. PubMed ID: 3281489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of alternative primary therapies for Plasmodium falciparum infections in Malawi.
    Heymann DL; Khoromana CO; Wirima JJ; Campbell CC
    Trans R Soc Trop Med Hyg; 1987; 81(5):722-4. PubMed ID: 3329780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum.
    Wang P; Wang Q; Aspinall TV; Sims PF; Hyde JE
    Mol Microbiol; 2004 Mar; 51(5):1425-38. PubMed ID: 14982635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of Plasmodium falciparum infections to pyrimethamine-sulfadoxine in Thailand.
    Rieckmann K; Suebsaeng L; Rooney W
    Am J Trop Med Hyg; 1987 Sep; 37(2):211-6. PubMed ID: 3310675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
    Pearson RD; Hewlett EL
    Ann Intern Med; 1987 May; 106(5):714-8. PubMed ID: 3551713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.